Table 4.

Clinical efficacy as demonstrated by pooled analysis of identified outcomes between the different treatment strategies.

Variable	EVT - Selective Stenting	EVT- Routine Stenting	CFE
Primary Patency at 1 yr [95% CI] [I2, p]	78%  [69-85]  [69.37%, p= 0.006]	84%  [75-92]  [75.52%, p=0.0004]	93%  [90-96]  [74.91%, p < 0.0001]
Primary Assisted Patency at 1 yr [95% CI] [I2, p]	86%  [67-97]  [91.8%, p < 0.0001]	94%  [83-99]  [81.29%, p = 0.0011]	97%  [94-99]  [90.87%, p < 0.0001]
Target Lesion revascularization at 1 yr [95% CI] [I2, p]	19%  [14-23]  [22.3%, p = 0.27]	8%  [4-13] [38.76%, p = 0.1628]	4.5%  [1-9]  [85.07%, p < 0.0001]
Amputations [95% CI] [I2, p]	3%  [1.3 to 5.3]  [ 14.5%, p=0.31]	3%  [1-6]  [0.36%, p=0.4]	4.5 [2.5- 6.8]  [75.32%, p< 0.0001]
30 days mortality [95% CI] [I2, p]	1%  [0.4-2]  [0%, p=0.43]	0.8%  [0.1-2]  [0%, p=0.9]	1.3%  [0.6-2]  [0%, p=0.56]
Local complications [95% CI] [I2, p]	7%  [3.3 to 11.8]  [77.08%, p=0.0001]	5.2  [1.8- 10.2]  [56.89%, p=0.04]	22.3%  [13.8-32]  [95.2%, p < 0.0001]

An I² more than 50% and a p less than 0.05 showing heterogeneity. Yr: year and CI: confidence interval.